Literature DB >> 32795182

Potential mechanism of left ventricular spherical remodeling: association of mitral valve complex-myocardium longitudinal tissue remodeling mismatch.

Yasufumi Nagata1,2, Mai Iwataki1, Yosuke Nabeshima1, Soshi Hei1, Takeshi Onoue1, Atsushi Hayashi1, Kyoko Otani3, Yuki Tsuda1, Masaru Araki1, Dae-Hee Kim4, Jae-Kwan Song4, Akihiro Hayashida5, Misako Toki6, Toshinori Yuasa7, Naoko Mizukami8, Yosuke Nishimura9, Robert A Levine2, Yutaka Otsuji1.   

Abstract

Since mitral valve (MV) complex (MVC) longitudinally bridges left ventricular (LV) base end and its middle, insufficient MVC longitudinal tissue length (TL) elongation relative to whole LV myocardial longitudinal TL elongation could limit LV-base-longitudinal-TL elongation, leading to predominant LV-base-transverse-TL elongation, constituting LV spherical remodeling. In 30 patients with dilated cardiomyopathy (DCM), 30 with aortic regurgitation (AR), and 30 controls, LV sphericity, LV-apex- or base-transverse- and longitudinal-TL, MVC-longitudinal-TL, and whole-LV-longitudinal-TL were measured by three-dimensional (3D) echocardiography. Ratio of each measure versus mean normal value (i.e., LV-apex-transverse-TL ratio) was considered to express the directional and regional tissue elongation. [LV-base-longitudinal-TL ratio/global-LV-TL ratio] and [MVC-longitudinal-TL ratio/whole-LV-longitudinal-TL ratio] were obtained as the degree of LV-base-longitudinal-TL or MVC-longitudinal-TL elongation relative to the whole LV elongation. LV-apex-transverse-, LV-apex-longitudinal-, and LV-base-transverse-TL ratios were significantly increased (1.27 to 1.42, P < 0.01) in both DCM and AR, while the LV-base-longitudinal-TL ratio was not increased in DCM [1.04 ± 0.19, not significant (ns)] and only modestly increased in AR (1.12 ± 0.21, P < 0.01). Whole-LV-longitudinal-TL ratio was significantly increased in both DCM and AR (1.22 ± 0.18 and 1.20 ± 0.16, P < 0.01), while MVC-longitudinal-TL ratio was not or only modestly increased in both groups (1.07 ± 0.15, ns, and 1.12 ± 0.17, P = 0.02, respectively). Multivariable analysis revealed that LV sphericity was independently related to a reduced [LV-base-longitudinal-TL ratio/global-LV-TL ratio] (standard β = -0.42, P < 0.01), which was further related to a reduced [MVC-longitudinal-TL ratio/whole-LV-longitudinal-TL ratio] (standard β = 0.72, P < 0.01). These are consistent with the hypothesis that relatively less MVC-longitudinal-TL elongation in the process of primary LV myocardial tissue elongation may limit LV-base-longitudinal-TL elongation, contributing to LV spherical remodeling.NEW & NOTEWORTHY Left ventricular (LV) spherical remodeling is associated with poor prognosis and less-effective cardiac performance, which commonly develops in dilated cardiomyopathy. However, its mechanism remains unclear. We hypothesized and subsequently clarified that less mitral valve complex (MVC) tissue longitudinal elongation relative to whole LV myocardial tissue longitudinal elongation is related to disproportionately less LV base longitudinal versus transverse myocardial tissue elongation, constituting spherical remodeling. This study suggests modification of MVC tissue elongation could be potential therapeutic targets.

Entities:  

Keywords:  3-D echocardiography; cardiomyopathy; heart failure; left ventricular remodeling

Mesh:

Year:  2020        PMID: 32795182      PMCID: PMC7938763          DOI: 10.1152/ajpheart.00279.2020

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  35 in total

1.  Left ventricular surgical restoration for anteroseptal scars: volume versus shape.

Authors:  Antonio M Calafiore; Angela L Iacò; Davide Amata; Cataldo Castello; Egidio Varone; Fabio Falconieri; Antonio Bivona; Sabina Gallina; Michele Di Mauro
Journal:  J Thorac Cardiovasc Surg       Date:  2010-05       Impact factor: 5.209

Review 2.  Mitral valve disease--morphology and mechanisms.

Authors:  Robert A Levine; Albert A Hagége; Daniel P Judge; Muralidhar Padala; Jacob P Dal-Bianco; Elena Aikawa; Jonathan Beaudoin; Joyce Bischoff; Nabila Bouatia-Naji; Patrick Bruneval; Jonathan T Butcher; Alain Carpentier; Miguel Chaput; Adrian H Chester; Catherine Clusel; Francesca N Delling; Harry C Dietz; Christian Dina; Ronen Durst; Leticia Fernandez-Friera; Mark D Handschumacher; Morten O Jensen; Xavier P Jeunemaitre; Hervé Le Marec; Thierry Le Tourneau; Roger R Markwald; Jean Mérot; Emmanuel Messas; David P Milan; Tui Neri; Russell A Norris; David Peal; Maelle Perrocheau; Vincent Probst; Michael Pucéat; Nadia Rosenthal; Jorge Solis; Jean-Jacques Schott; Ehud Schwammenthal; Susan A Slaugenhaupt; Jae-Kwan Song; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2015-10-20       Impact factor: 32.419

3.  Left ventricular surgical remodelling: is it a matter of shape or volume?.

Authors:  Michele Di Mauro; Angela L Iacò; Sabrina Bencivenga; Daniela Clemente; Serena Marcon; Mahmood Asif; Maria Cristina Di Saverio; Silvio Romano; Sabina Gallina; Maria Penco; Antonio M Calafiore
Journal:  Eur J Cardiothorac Surg       Date:  2014-05-06       Impact factor: 4.191

4.  Left ventricular function in chronic mitral regurgitation: preoperative and postoperative comparison.

Authors:  W J Corin; G Sütsch; T Murakami; O N Krogmann; M Turina; O M Hess
Journal:  J Am Coll Cardiol       Date:  1995-01       Impact factor: 24.094

5.  Elongation of chordae tendineae as an adaptive process to reduce mitral regurgitation in functional mitral regurgitation.

Authors:  Kikuko Obase; Lynn Weinert; Andrew Hollatz; Farhan Farooqui; Joseph D Roberts; Mohammed M Minhaj; Avery Tung; Mark Chaney; Takeyoshi Ota; Valluvan Jeevanandam; Kiyoshi Yoshida; Victor Mor-Avi; Roberto M Lang
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-12-28       Impact factor: 6.875

6.  Active adaptation of the tethered mitral valve: insights into a compensatory mechanism for functional mitral regurgitation.

Authors:  Jacob P Dal-Bianco; Elena Aikawa; Joyce Bischoff; J Luis Guerrero; Mark D Handschumacher; Suzanne Sullivan; Benjamin Johnson; James S Titus; Yoshiko Iwamoto; Jill Wylie-Sears; Robert A Levine; Alain Carpentier
Journal:  Circulation       Date:  2009-07-13       Impact factor: 29.690

7.  Coronary bypass surgery with or without surgical ventricular reconstruction.

Authors:  Robert H Jones; Eric J Velazquez; Robert E Michler; George Sopko; Jae K Oh; Christopher M O'Connor; James A Hill; Lorenzo Menicanti; Zygmunt Sadowski; Patrice Desvigne-Nickens; Jean-Lucien Rouleau; Kerry L Lee
Journal:  N Engl J Med       Date:  2009-03-29       Impact factor: 91.245

8.  Insights into the mechanism of paradoxical low-flow, low-pressure gradient severe aortic stenosis: association with reduced O2 consumption by the whole body.

Authors:  Takeshi Onoue; Mai Iwataki; Masaru Araki; Hideaki Itoh; Akihiro Isotani; Hiromi Umeda; Shota Fukuda; Yasufumi Nagata; Yuki Tsuda; Yoshihisa Fujino; Michiya Hanyu; Kenji Ando; Shinichi Shirai; Masaaki Takeuchi; Satoru Saeki; Robert A Levine; Yutaka Otsuji
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-01-25       Impact factor: 4.733

9.  Mitral valve enlargement in chronic aortic regurgitation as a compensatory mechanism to prevent functional mitral regurgitation in the dilated left ventricle.

Authors:  Jonathan Beaudoin; Mark D Handschumacher; Xin Zeng; Judy Hung; Eleanor L Morris; Robert A Levine; Ehud Schwammenthal
Journal:  J Am Coll Cardiol       Date:  2013-02-28       Impact factor: 24.094

10.  Expression of matrix metalloproteinase activity in idiopathic dilated cardiomyopathy: a marker of cardiac dilatation.

Authors:  Hanumanth K Reddy; Imam E Tjahja; Scott E Campbell; Joseph S Janicki; Melvin R Hayden; Suresh C Tyagi
Journal:  Mol Cell Biochem       Date:  2004-09       Impact factor: 3.396

View more
  1 in total

Review 1.  Echocardiographic Advances in Dilated Cardiomyopathy.

Authors:  Andrea Faggiano; Carlo Avallone; Domitilla Gentile; Giovanni Provenzale; Filippo Toriello; Marco Merlo; Gianfranco Sinagra; Stefano Carugo
Journal:  J Clin Med       Date:  2021-11-25       Impact factor: 4.241

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.